Mesenchymal stem cells as a promising cell source for integration in novel in vitro models

Ann Kristin Afflerbach, Mark D. Kiri, Tahir Detinis, Ben M. Maoz*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


The human-relevance of an in vitro model is dependent on two main factors—(i) an appropriate human cell source and (ii) a modeling platform that recapitulates human in vivo conditions. Recent years have brought substantial advancements in both these aspects. In particular, mesenchymal stem cells (MSCs) have emerged as a promising cell source, as these cells can differentiate into multiple cell types, yet do not raise the ethical and practical concerns associated with other types of stem cells. In turn, advanced bioengineered in vitro models such as microfluidics, Organs-on-a-Chip, scaffolds, bioprinting and organoids are bringing researchers ever closer to mimicking complex in vivo environments, thereby overcoming some of the limitations of traditional 2D cell cultures. This review covers each of these advancements separately and discusses how the integration of MSCs into novel in vitro platforms may contribute enormously to clinical and fundamental research.

Original languageEnglish
Article number1306
Pages (from-to)1-30
Number of pages30
Issue number9
StatePublished - Sep 2020


  • In vitro models
  • Mesenchymal stem cells
  • Microfluidics
  • Organoids
  • Organs-on-a-chip
  • Scaffolds


Dive into the research topics of 'Mesenchymal stem cells as a promising cell source for integration in novel in vitro models'. Together they form a unique fingerprint.

Cite this